This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
For individuals suffering from Major Depressive Disorder and are not responding well to anti-depressant medication we offer a new treatment option cleared by the FDA. Transcranial Magnetic Stimulation or TMS is a non-invasive brain stimulation procedure that lasts 20-30 minutes per treatment. TMS also received clearance for marketing as treatment for obsessive compulsive disorder (OCD), PTSD and bipolar disorder.
Please fill all the marked fields